Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Susan R. Schwab,1João P. Pereira,1Mehrdad Matloubian,1Ying Xu,1Yong Huang,2Jason G. Cyster1*
Lymphocyte egress from the thymus and from peripheral lymphoidorgans depends on sphingosine 1-phosphate (S1P) receptor-1 andis thought to occur in response to circulatory S1P. However,the existence of an S1P gradient between lymphoid organs andblood or lymph has not been established. To further define egressrequirements, we addressed why treatment with the food colorant2-acetyl-4-tetrahydroxybutylimidazole (THI) induces lymphopenia.We found that S1P abundance in lymphoid tissues of mice is normallylow but increases more than 100-fold after THI treatment andthat this treatment inhibits the S1P-degrading enzyme S1P lyase.We conclude that lymphocyte egress is mediated by S1P gradientsthat are established by S1P lyase activity and that the lyasemay represent a novel immunosuppressant drug target.
1 Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 941430414, USA. 2 Drug Studies Unit, Department of Biopharmaceutical Sciences, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 941430414, USA.
* To whom correspondence should be addressed. E-mail: cyster{at}itsa.ucsf.edu
T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow.
C. N. Jenne, A. Enders, R. Rivera, S. R. Watson, A. J. Bankovich, J. P. Pereira, Y. Xu, C. M. Roots, J. N. Beilke, A. Banerjee, et al. (2009)
J. Exp. Med.
206, 2469-2481
|Abstract »|Full Text »|PDF »
Discontinued Postnatal Thymocyte Development in Sphingosine 1-Phosphate-Lyase-Deficient Mice.
C. Weber, A. Krueger, A. Munk, C. Bode, P. P. Van Veldhoven, and M. H. Graler (2009)
J. Immunol.
183, 4292-4301
|Abstract »|Full Text »|PDF »
Involvement of Sphingosine 1-Phosphate (SIP)/S1P3 Signaling in Cholestasis-Induced Liver Fibrosis.
C. Li, X. Jiang, L. Yang, X. Liu, S. Yue, and L. Li (2009)
Am. J. Pathol.
175, 1464-1472
|Abstract »|Full Text »|PDF »
Characterization of the ATP-dependent Sphingosine 1-Phosphate Transporter in Rat Erythrocytes.
N. Kobayashi, N. Kobayashi, A. Yamaguchi, and T. Nishi (2009)
J. Biol. Chem.
284, 21192-21200
|Abstract »|Full Text »|PDF »
Distinct Roles of Sphingosine Kinase 1 and 2 in Murine Collagen-Induced Arthritis.
W.-Q. Lai, A. W. Irwan, H. H. Goh, A. J. Melendez, I. B. McInnes, and B. P. Leung (2009)
J. Immunol.
183, 2097-2103
|Abstract »|Full Text »|PDF »
Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor.
J.-J. Liao, M.-C. Huang, K. Fast, K. Gundling, M. Yadav, J. R. Van Brocklyn, M. R. Wabl, and E. J. Goetzl (2009)
FASEB J
23, 1786-1796
|Abstract »|Full Text »|PDF »
Regulation of vascular physiology and pathology by the S1P2 receptor subtype.
Accumulation of Fingolimod (FTY720) in Lymphoid Tissues Contributes to Prolonged Efficacy.
S.-C. Sensken, C. Bode, and M. H. Graler (2009)
J. Pharmacol. Exp. Ther.
328, 963-969
|Abstract »|Full Text »|PDF »
Role of the Molybdoflavoenzyme Aldehyde Oxidase Homolog 2 in the Biosynthesis of Retinoic Acid: Generation and Characterization of a Knockout Mouse.
M. Terao, M. Kurosaki, M. M. Barzago, M. Fratelli, R. Bagnati, A. Bastone, C. Giudice, E. Scanziani, A. Mancuso, C. Tiveron, et al. (2009)
Mol. Cell. Biol.
29, 357-377
|Abstract »|Full Text »|PDF »
Sphingolipids in the Lungs.
S. Uhlig and E. Gulbins (2008)
Am. J. Respir. Crit. Care Med.
178, 1100-1114
|Abstract »|Full Text »|PDF »
P. S. Kunwar, H. Sano, A. D. Renault, V. Barbosa, N. Fuse, and R. Lehmann (2008)
J. Cell Biol.
183, 157-168
|Abstract »|Full Text »|PDF »
Local Not Systemic Modulation of Dendritic Cell S1P Receptors in Lung Blunts Virus-Specific Immune Responses to Influenza.
D. Marsolais, B. Hahm, K. H. Edelmann, K. B. Walsh, M. Guerrero, Y. Hatta, Y. Kawaoka, E. Roberts, M. B. A. Oldstone, and H. Rosen (2008)
Mol. Pharmacol.
74, 896-903
|Abstract »|Full Text »|PDF »
Thymic Emigration: When and How T Cells Leave Home.
Identifying Key Residues of Sphinganine-1-phosphate Lyase for Function in Vivo and in Vitro.
D. Mukhopadhyay, K. S. Howell, H. Riezman, and G. Capitani (2008)
J. Biol. Chem.
283, 20159-20169
|Abstract »|Full Text »|PDF »
"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets.
K. Takabe, S. W. Paugh, S. Milstien, and S. Spiegel (2008)
Pharmacol. Rev.
60, 181-195
|Abstract »|Full Text »|PDF »
Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NF{kappa}B-inducing kinase in stromal cells.
J. Kunisawa, M. Gohda, Y. Kurashima, I. Ishikawa, M. Higuchi, and H. Kiyono (2008)
Blood
111, 4646-4652
|Abstract »|Full Text »|PDF »
Sphingosine 1-Phosphate Regulates the Egress of IgA Plasmablasts from Peyer's Patches for Intestinal IgA Responses.
M. Gohda, J. Kunisawa, F. Miura, Y. Kagiyama, Y. Kurashima, M. Higuchi, I. Ishikawa, I. Ogahara, and H. Kiyono (2008)
J. Immunol.
180, 5335-5343
|Abstract »|Full Text »|PDF »
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate.
K. Venkataraman, Y.-M. Lee, J. Michaud, S. Thangada, Y. Ai, H. L. Bonkovsky, N. S. Parikh, C. Habrukowich, and T. Hla (2008)
Circ. Res.
102, 669-676
|Abstract »|Full Text »|PDF »
S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues.
M. L. Allende, D. Zhou, D. N. Kalkofen, S. Benhamed, G. Tuymetova, C. Borowski, A. Bendelac, and R. L. Proia (2008)
FASEB J
22, 307-315
|Abstract »|Full Text »|PDF »
A rapid fluorescence assay for sphingosine-1-phosphate lyase enzyme activity.
P. Bandhuvula, H. Fyrst, and J. D. Saba (2007)
J. Lipid Res.
48, 2769-2778
|Abstract »|Full Text »|PDF »
Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium.
J. Kunisawa, Y. Kurashima, M. Higuchi, M. Gohda, I. Ishikawa, I. Ogahara, N. Kim, M. Shimizu, and H. Kiyono (2007)
J. Exp. Med.
204, 2335-2348
|Abstract »|Full Text »|PDF »
A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.
Z.-Q. Jin, J. Zhang, Y. Huang, H. E. Hoover, D. A. Vessey, and J. S. Karliner (2007)
Cardiovasc Res
76, 41-50
|Abstract »|Full Text »|PDF »
Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate.
R. Pappu, S. R. Schwab, I. Cornelissen, J. P. Pereira, J. B. Regard, Y. Xu, E. Camerer, Y.-W. Zheng, Y. Huang, J. G. Cyster, et al. (2007)
Science
316, 295-298
|Abstract »|Full Text »|PDF »
Erythrocytes store and release sphingosine 1-phosphate in blood.
A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress.
C. Nombela-Arrieta, T. R. Mempel, S. F. Soriano, I. Mazo, M. P. Wymann, E. Hirsch, C. Martinez-A., Y. Fukui, U. H. von Andrian, and J. V. Stein (2007)
J. Exp. Med.
204, 497-510
|Abstract »|Full Text »|PDF »
CC Chemokine Receptor 7 Contributes to Gi-Dependent T Cell Motility in the Lymph Node.
The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors.
S. G. Payne, C. A. Oskeritzian, R. Griffiths, P. Subramanian, S. E. Barbour, C. E. Chalfant, S. Milstien, and S. Spiegel (2007)
Blood
109, 1077-1085
|Abstract »|Full Text »|PDF »
Distinctive T Cell-suppressive Signals from Nuclearized Type 1 Sphingosine 1-Phosphate G Protein-coupled Receptors.
J.-J. Liao, M.-C. Huang, M. Graler, Y. Huang, H. Qiu, and E. J. Goetzl (2007)
J. Biol. Chem.
282, 1964-1972
|Abstract »|Full Text »|PDF »
Sphingosine-1-Phosphate Modulates Both Lipolysis and Leptin Production in Differentiated Rat White Adipocytes.
D.-J. Jun, J.-H. Lee, B.-H. Choi, T.-K. Koh, D.-C. Ha, M.-W. Jeong, and K.-T. Kim (2006)
Endocrinology
147, 5835-5844
|Abstract »|Full Text »|PDF »
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism.
K. Kabashima, N. M. Haynes, Y. Xu, S. L. Nutt, M. L. Allende, R. L. Proia, and J. G. Cyster (2006)
J. Exp. Med.
203, 2683-2690
|Abstract »|Full Text »|PDF »
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.
E. Kamphuis, T. Junt, Z. Waibler, R. Forster, and U. Kalinke (2006)
Blood
108, 3253-3261
|Abstract »|Full Text »|PDF »
Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer.
B. Oskouian, P. Sooriyakumaran, A. D. Borowsky, A. Crans, L. Dillard-Telm, Y. Y. Tam, P. Bandhuvula, and J. D. Saba (2006)
PNAS
103, 17384-17389
|Abstract »|Full Text »|PDF »
Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation..
M. Kohno, M. Momoi, M. L. Oo, J.-H. Paik, Y.-M. Lee, K. Venkataraman, Y. Ai, A. P. Ristimaki, H. Fyrst, H. Sano, et al. (2006)
Mol. Cell. Biol.
26, 7211-7223
|Abstract »|Full Text »|PDF »
Sphingosine 1-Phosphate Affects Cytokine-Induced Apoptosis in Rat Pancreatic Islet {beta}-Cells.
S. G. Laychock, S. M. Sessanna, M.-H. Lin, and L. D. Mastrandrea (2006)
Endocrinology
147, 4705-4712
|Abstract »|Full Text »|PDF »
The value of animal models for drug development in multiple sclerosis.
M. A. Friese, X. Montalban, N. Willcox, J. I. Bell, R. Martin, and L. Fugger (2006)
Brain
129, 1940-1952
|Abstract »|Full Text »|PDF »